This research trial studies biomarkers in samples from patients with rhabdoid tumor of the kidney and atypical teratoid rhabdoid tumor. Studying biomarkers of tissue samples from patients with cancer in the laboratory may help doctors learn more about changes the occur in DNA and identify biomarkers related to cancer.
PRIMARY OBJECTIVES: I. To determine if there are molecular differences between rhabdoid tumor of the kidney (RTK) and the atypical teratoid rhabdoid tumor (ATRT). OUTLINE: Archived tumor tissue samples are analyzed for gene expression profile and microRNA profile.
Study Type
OBSERVATIONAL
Correlative studies
Childrens Oncology Group
Philadelphia, Pennsylvania, United States
Molecular differences between RTK and the ATRT
Time frame: Up to 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.